5-170789140-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_014211.3(GABRP):ā€‹c.65A>Gā€‹(p.Gln22Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,612,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.0000066 ( 0 hom., cov: 32)
Exomes š‘“: 0.0000014 ( 0 hom. )

Consequence

GABRP
NM_014211.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.622
Variant links:
Genes affected
GABRP (HGNC:4089): (gamma-aminobutyric acid type A receptor subunit pi) The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. The subunit encoded by this gene is expressed in several non-neuronal tissues including the uterus and ovaries. This subunit can assemble with known GABA A receptor subunits, and the presence of this subunit alters the sensitivity of recombinant receptors to modulatory agents such as pregnanolone. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07801032).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GABRPNM_014211.3 linkuse as main transcriptc.65A>G p.Gln22Arg missense_variant 3/10 ENST00000265294.9 NP_055026.1
GABRPNM_001291985.2 linkuse as main transcriptc.65A>G p.Gln22Arg missense_variant 3/9 NP_001278914.1
GABRPXM_024446012.2 linkuse as main transcriptc.65A>G p.Gln22Arg missense_variant 3/10 XP_024301780.1
GABRPXM_005265872.2 linkuse as main transcriptc.-66+472A>G intron_variant XP_005265929.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GABRPENST00000265294.9 linkuse as main transcriptc.65A>G p.Gln22Arg missense_variant 3/101 NM_014211.3 ENSP00000265294 P1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152208
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1460554
Hom.:
0
Cov.:
30
AF XY:
0.00000275
AC XY:
2
AN XY:
726618
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000656
AC:
1
AN:
152326
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 11, 2022The c.65A>G (p.Q22R) alteration is located in exon 3 (coding exon 2) of the GABRP gene. This alteration results from a A to G substitution at nucleotide position 65, causing the glutamine (Q) at amino acid position 22 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.014
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
12
DANN
Benign
0.84
DEOGEN2
Benign
0.060
.;.;.;.;T;.;T;.;.
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.59
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.61
T;T;T;T;.;T;T;T;T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.078
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.55
.;.;.;.;N;.;N;.;.
MutationTaster
Benign
0.99
N;N;N;N
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.21
N;N;N;N;N;D;N;N;N
REVEL
Benign
0.18
Sift
Benign
0.23
T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.52
T;T;T;T;T;T;T;T;T
Polyphen
0.0
.;.;.;.;B;.;B;B;.
Vest4
0.17, 0.18, 0.15, 0.15
MutPred
0.40
Gain of methylation at Q22 (P = 0.0601);Gain of methylation at Q22 (P = 0.0601);Gain of methylation at Q22 (P = 0.0601);Gain of methylation at Q22 (P = 0.0601);Gain of methylation at Q22 (P = 0.0601);Gain of methylation at Q22 (P = 0.0601);Gain of methylation at Q22 (P = 0.0601);Gain of methylation at Q22 (P = 0.0601);Gain of methylation at Q22 (P = 0.0601);
MVP
0.78
MPC
0.13
ClinPred
0.16
T
GERP RS
3.9
Varity_R
0.082
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs571307888; hg19: chr5-170216144; API